Annual SG&A
$288.93M$138.34M+91.87%
Summary
- Current Value
- As of today, BBIO annual SG&A is $288.93M, up +91.87% on
- Historical Performance
- BBIO annual SG&A is up +50.32% over the past 3 years, and up +206.22% over the past 5 years
- All-Time High Comparison
- BBIO annual SG&A is currently at its all-time high
- 3-Year Low Comparison
- BBIO annual SG&A is +101.78% above its 3-year low of $143.19M reached on an earlier date
- Sector Comparison
- BBIO annual SG&A is higher than 91.88% of companies in Healthcare sector
SG&A Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual SG&A | $288.93M | +91.9% | +50.3% | +206.2% | +2072.1% | |
| Quarterly SG&A | $137.62M | +100.0% | +341.3% | +282.1% | +1618.8% | |
| TTM SG&A | -$13.43B | -5657.3% | -8189.0% | -9480.0% | -10000.0% | |
| Price | $74.27 | +157.4% | +905.0% | +14.6% | – | |
| Annual Operating Expenses | $795.39M | +31.2% | +23.7% | +161.4% | +1713.6% | |
| Annual Operating Profit | -$577.37M | +3.7% | -0.1% | -116.9% | -1216.5% | |
| Annual D&A | $6.08M | -6.5% | +4.0% | – | +2236.5% | |
| Annual Revenue | $221.90M | +2285.3% | +218.3% | +447.1% | +100.0% |
SG&A Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $288.93M | at high | |
| 5Y | $288.93M | at high | |
| All | $288.93M | at high |
SG&A Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $143.19M | N/A | +101.8% |
| 5Y | $143.19M | +101.8% | |
| All | $13.30M | +2072.1% |
SG&A History
| Year | Value | Change |
|---|---|---|
| $288.93M | +91.9% | |
| $150.59M | +5.2% | |
| $143.19M | -25.5% | |
| $192.21M | +31.9% |
| Year | Value | Change |
|---|---|---|
| $145.68M | +54.4% | |
| $94.35M | +116.5% | |
| $43.59M | +227.7% | |
| $13.30M | - |
FAQ
What is the current annual SG&A of BBIO?
As of today, BBIO annual SG&A is $288.93M
What is 1-year change in BBIO annual SG&A?
BBIO annual SG&A is up +91.87% year-over-year
What is 3-year change in BBIO annual SG&A?
BBIO annual SG&A is up +50.32% over the past 3 years
How far is BBIO annual SG&A from its all-time high?
BBIO annual SG&A is currently at its all-time high
How does BBIO annual SG&A rank versus sector peers?
BBIO annual SG&A is higher than 91.88% of companies in Healthcare sector
When is BBIO next annual earnings release?
The next annual earnings release for BBIO is on
Quarterly SG&A
$137.62M$8.47M+6.56%
Summary
- Current Value
- As of today, BBIO quarterly SG&A is $137.62M, up +6.56% on
- Historical Performance
- BBIO quarterly SG&A is up +99.98% year-over-year, and up +341.26% over the past 3 years
- All-Time High Comparison
- BBIO quarterly SG&A is currently at its all-time high
- 3-Year Low Comparison
- BBIO quarterly SG&A is +342.40% above its 3-year low of $31.11M reached on
- Sector Comparison
- BBIO quarterly SG&A is higher than 92.06% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly SG&A | $137.62M | +6.6% | +100.0% | +341.3% | +282.1% | |
| Annual SG&A | $288.93M | – | +91.9% | +50.3% | +206.2% | |
| TTM SG&A | -$13.43B | -3465.9% | -5657.3% | -8189.0% | -9480.0% | |
| Price | $74.27 | +37.0% | +157.4% | +905.0% | +14.6% | |
| Quarterly Operating Expenses | $249.80M | +4.2% | +32.9% | +103.7% | +95.0% | |
| Quarterly Operating Profit | -$136.36M | -2.2% | +27.1% | -9.9% | -13.7% | |
| Quarterly D&A | $1.40M | +6.2% | -9.1% | -15.0% | – | |
| Quarterly Revenue | $120.70M | +9.2% | +4318.0% | +10000.0% | +1385.2% |
Quarterly SG&A Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $137.62M | at high | |
| 3Y | $137.62M | at high | |
| 5Y | $137.62M | at high | |
| All | $137.62M | at high |
Quarterly SG&A Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $94.78M | N/A | +45.2% |
| 3Y | $31.11M | +342.4% | |
| 5Y | $31.11M | +342.4% | |
| All | $0.00 | N/A |
Quarterly SG&A History
FAQ
What is the current quarterly SG&A of BBIO?
As of today, BBIO quarterly SG&A is $137.62M
What is BBIO quarterly SG&A most recent change?
BBIO quarterly SG&A was up +6.56% on September 30, 2025
What is 1-year change in BBIO quarterly SG&A?
BBIO quarterly SG&A is up +99.98% year-over-year
How far is BBIO quarterly SG&A from its all-time high?
BBIO quarterly SG&A is currently at its all-time high
How does BBIO quarterly SG&A rank versus sector peers?
BBIO quarterly SG&A is higher than 92.06% of companies in Healthcare sector
When is BBIO next earnings release?
The next earnings release for BBIO is on
TTM SG&A
-$13.43B$797.12M-6.31%
Summary
- Current Value
- As of today, BBIO TTM SG&A is -$13.43B, down -6.31% on
- Historical Performance
- BBIO TTM SG&A is down -5657.34% year-over-year, and down -8188.99% over the past 3 years
- All-Time High Comparison
- BBIO TTM SG&A is currently -7775.41% below its historical high of -$170.58M set on an earlier date
- 3-Year Low Comparison
- BBIO TTM SG&A is at its 3-year low
- Sector Comparison
- BBIO TTM SG&A is higher than 1.96% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM SG&A | -$13.43B | -3465.9% | -5657.3% | -8189.0% | -9480.0% | |
| Annual SG&A | $288.93M | – | +91.9% | +50.3% | +206.2% | |
| Quarterly SG&A | $137.62M | +6.6% | +100.0% | +341.3% | +282.1% | |
| Price | $74.27 | +37.0% | +157.4% | +905.0% | +14.6% | |
| TTM Operating Profit | -$594.97M | +7.9% | -11.7% | -15.7% | -39.8% | |
| TTM D&A | $5.37M | -2.5% | -14.7% | -19.1% | – | |
| TTM Revenue | $353.78M | +50.0% | +62.5% | +299.0% | +1512.0% |
TTM SG&A Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | -$11.19B | N/A | -20.0% |
| 3Y | -$6.98B | N/A | -92.6% |
| 5Y | -$2.84B | N/A | -372.6% |
| All | -$170.58M | N/A | -7775.4% |
TTM SG&A Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$13.43B | N/A | at low |
| 3Y | -$13.43B | N/A | at low |
| 5Y | -$13.43B | N/A | at low |
| All | -$13.43B | N/A | at low |
TTM SG&A History
FAQ
What is the current TTM SG&A of BBIO?
As of today, BBIO TTM SG&A is -$13.43B
What is BBIO TTM SG&A most recent change?
BBIO TTM SG&A was down -6.31% on September 30, 2025
What is 1-year change in BBIO TTM SG&A?
BBIO TTM SG&A is down -5657.34% year-over-year
How does BBIO TTM SG&A rank versus sector peers?
BBIO TTM SG&A is higher than 1.96% of companies in Healthcare sector
When is BBIO next earnings release?
The next earnings release for BBIO is on
Selling, General & Administrative Expenses Formula
SG&A = − − R&D
Data Sources & References
- BBIO Official Website bridgebio.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1743881/000174388125000012/0001743881-25-000012-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1743881/000095017025024119/0000950170-25-024119-index.htm
- BBIO Profile on Yahoo Finance finance.yahoo.com/quote/BBIO
- BBIO Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/bbio